Updates in the Treatment of HER2+ Metastatic Breast Cancer

Discussion of recent clinical trial updates in HER2-positive metastatic breast cancer and implications for managing 2 patient case scenarios.

EP. 11: Review of Key Data Supporting Recent Developments in the HER2+ mBC Landscape

October 6th 2022

An expert breast medical oncologist discusses recent changes to HER2+ mBC treatment guidelines due to key findings from the DESTINY-Breast03 trial.

EP. 12: The Impact of Brain Metastases on Treatment Selection in Patients with HER2+ mBC

October 13th 2022

Insights concerning the selection of effective treatment approaches for patients with HER2+ mBC presenting with brain metastases and other complications.

EP. 13: New Data and Guidelines Concerning HER2+ mBC Therapy Sequencing

October 13th 2022

Discussion centered around the latest data and guideline updates, and how these changes affect therapy sequencing in the first, second, and third lines of treatment.

EP. 14: Considering Pulmonary Status: Monitoring for Interstitial Lung Disease

October 20th 2022

Clinically relevant advice for the monitoring and management of pulmonary complications in patients with HER2+ mBC.

EP. 15: HER2+ mBC Trials in Progress and Other Exciting Prospects on the Horizon

October 20th 2022

Dr. Neil M. Iyengar closes the discussion with preliminary results from a phase I study, thoughts on use of biosimilars, and other in-progress trials of interest.